Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Therapeutic Drug Monitoring|June 17, 2006
Sequence-based CYP2D6 genotyping in the Korean populationSoo-Youn Lee, Kwang Min Sohn, Ji Young Ryu, et al.
Journal of Psychopharmacology (Oxford, England)|December 19, 2013
Changes in plasma concentrations of risperidone and 9-hydroxyrisperidone and the associated clinical effects during the switch from oral risperidone to extended-release paliperidone tablets in patients with schizophreniaDong Suk Yang, Sook Jin Seong, Young-Ran Yoon, et al.
Basic & Clinical Pharmacology & Toxicology|March 12, 2014
Semi-mechanistic modelling and simulation of inhibition of platelet aggregation by antiplatelet agentsHwi-yeol Yun, Wonku Kang, Byung-yo Lee, et al.
Drug Design, Development and Therapy|March 14, 2022
Pharmacokinetics and Pharmacodynamics of YYD601, a Dual Delayed-Release Formulation of Esomeprazole, Following Single and Multiple Doses in Healthy Adult Volunteers Under Fasting and Fed ConditionsHae Won Lee, Woo Youl Kang, Wookjae Jung, et al.
Molecules (Basel, Switzerland)|July 4, 2018
A Pharmacometabolomic Approach to Predict Response to Metformin in Early-Phase Type 2 Diabetes Mellitus PatientsJeong-Eun Park, Gui-Hwa Jeong, In-Kyu Lee, et al.
Clinical Pharmacology in Drug Development|August 25, 2023
Comparative Pharmacokinetic Profiles of a Novel Low-Dose Micronized Formulation of Raloxifene 45 mg (AD-101) and the Conventional Raloxifene 60 mg in Healthy SubjectsHae Won Lee, Woo Youl Kang, Mi-Ri Gwon, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 10, 2021
Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled TrialYu-Jin Kwon, Hyangkyu Lee, Chung Mo Nam, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2022
Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis PatientsHwi-Yeol Yun, Min Jung Chang, Heeyoon Jung, et al.
Experimental Cell Research|August 7, 2017
Neuromedin B and its receptor silencing suppresses osteoclast generation by modulating precursor proliferation via M-CSF/c-Fms/D-type cyclinsChae-Eun Yeo, Woo Youl Kang, Sook Jin Seong, et al.
Cellular Signalling|November 13, 2016
Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclastsHyun-Ju Kim, Boram Ohk, Hye Jin Yoon, et al.
Pageof 12